Real-world treatment patterns and outcomes of patients with multiple myeloma initiating elranatamab: results from the ALTITUDE-1 and ALTITUDE-2 retrospective cohort studies

Key Points

• To assess the real-world treatment patterns and effectiveness of elranatamab in patients with multiple myeloma.
• Analyzed data from ALTITUDE-1 and ALTITUDE-2 retrospective cohort studies.
• Examined treatment patterns and outcomes of US patients initiating elranatamab.
• Compared real-world findings with results from MagnetisMM-3 trial (NCT04649359).
• Patients were heavily pre-treated before starting elranatamab.
• Less frequent administration of elranatamab was observed compared to labeled indications.
• Effectiveness aligned with findings from the MagnetisMM-3 clinical trial.